Emerging evidence suggests that IL-1β may serve as a serum biomarker for identifying severe and persistent cases of allergic rhinitis and asthma [116,117] and contributes to allergic inflammation by promoting neutrophil recruitment, airway hyperresponsiveness, and mucus secretion [118,119]. This evidence concerns the gene IL1B and asthma.